The extracellular volume status predicts body fluid response to SGLT2 inhibitor dapagliflozin in diabetic kidney diseaseKen Ohara, Daisuke Nagata, Takuya Murakami et al.|Diabetology & Metabolic Syndrome|2020Cited by 66
Impact of serum albumin levels on the body fluid response to tolvaptan in chronic kidney disease patientsTakahiro Masuda, Daisuke Nagata, Ken Ohara et al.|International Urology and Nephrology|2019Cited by 23
Anti-Neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis and Malignancy: A Case of a Patient Diagnosed with Renal Failure and Pulmonary Carcinoma ConcurrentlyMaki Asakura, Daisuke Nagata, Osamu Saitô et al.|Clinical Medicine Insights Case Reports|2021Cited by 4